IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
3
Bullish
36
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Discovery themes featuring this stockUpcoming Result Date: Nov 15, 2026
Investor Presentation
Q4 FY26
Boston Commerce Limited (BOSTONBIO) is currently trading at 12.12 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Boston Commerce Limited (formerly Boston Bio Systems Limited) is a small Indian company trading medical equipment, testing kits and instruments, and providing contract manufacturing, private labelling and end-to-end product development for herbal and health-related products and supplements; the firm also supplies custom buffers and formulation services to other businesses in the natural wellness sector. The company reported a large audited net loss of Rs. 717.61 lakhs for FY2025-26, earnings per share of (Rs. 10.25), and total assets of Rs. 76.86 lakhs; these numbers reflect a material write-off of balances during Q4, which auditors say casts significant doubt on the company’s ability to continue as a going concern. The statutory auditor issued a qualified opinion due to material write-offs of a majority of assets and liabilities, and the company’s non-payment of TDS during FY2025-26; management asserts write-offs were for old, non-recoverable and non-traceable balances, but shareholder special resolution to authorize the write-off was not provided to auditors. Liquidity is very constrained: cash and cash equivalents stood at Rs. 8.45 lakhs at year-end, net worth is negative at Rs. (127.15) lakhs, and lease and other current liabilities remain significant; despite a reported positive net operating cash flow figure in the statement, the balance sheet shows a stressed capital structure requiring urgent remedial action.
Over the past 52 weeks, Boston Commerce Limited has traded between a low of ₹4.01 and a high of ₹11.93. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Boston Commerce Limited has a market capitalization of approximately 8.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Boston Commerce Limited’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -14.40 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 8.35 Cr, Boston Commerce Limited is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Boston Commerce Limited operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Boston Commerce Limited is -14.40. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Boston Commerce reported a net loss of ₹0.5808 crore for the full year ended March 31, 2026, as per its audited standalone results.
Boston Commerce Limited (formerly Boston Bio Systems Limited) is a small Indian company trading medical equipment, testing kits and instruments, and providing contract manufacturing, private labelling and end-to-end product development for herbal and health-related products and supplements; the firm also supplies custom buffers and formulation services to other businesses in the natural wellness sector.
The company reported a large audited net loss of Rs. 717.61 lakhs for FY2025-26, earnings per share of (Rs. 10.25), and total assets of Rs. 76.86 lakhs; these numbers reflect a material write-off of balances during Q4, which auditors say casts significant doubt on the company’s ability to continue as a going concern.
The statutory auditor issued a qualified opinion due to material write-offs of a majority of assets and liabilities, and the company’s non-payment of TDS during FY2025-26; management asserts write-offs were for old, non-recoverable and non-traceable balances, but shareholder special resolution to authorize the write-off was not provided to auditors.
Liquidity is very constrained: cash and cash equivalents stood at Rs. 8.45 lakhs at year-end, net worth is negative at Rs. (127.15) lakhs, and lease and other current liabilities remain significant; despite a reported positive net operating cash flow figure in the statement, the balance sheet shows a stressed capital structure requiring urgent remedial action.
Healthcare Services
Healthcare Service Provider
8 Cr
Low Risk
-14.6
59.6
—
—
11.93
4.01
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1.96 | 11 Cr | -1.26 | 1.12 | 0.00 | -46.60 | -27.58 | -19.52 | ||
20.99 | 9 Cr | 16.86 | 0.82 | 0.00 | 3.81 | 3.58 | 2.90 | ||
11.93 | 8 Cr | -14.40 | 0.00 | 0.00 | -10.91 | 0.16 | -7.87 | ||
30.00 | 7 Cr | 16.31 | 0.74 | 0.00 | 4.52 | 6.80 | 3.67 | ||
6.60 | 6 Cr | 81.43 | 0.40 | 0.00 | 0.45 | 0.71 | 0.40 | ||
4.73 | 6 Cr | -56.80 | 0.51 | 0.00 | -1.16 | 0.77 | -0.67 | ||
4.32 | 4 Cr | -4.66 | 0.24 | 0.00 | -3.76 | -1.02 | -2.81 | ||
| Median: 7 Co. | — | 6.60 | 7 Cr | -1.26 | 0.51 | 0.00 | -1.16 | 0.71 | -0.67 |
